After racing out to a fast start in its first year on the market, Novo Nordisk’s GLP-1 diabetes superstar Ozempic is already proving a darling for the Danish drugmaker. Now, a heart-helping FDA approval will likely spell even more success for the standout––and bodes well for Novo’s other much-touted diabetes launch. The FDA approved Ozempic to reduce the… Read More »
Johnson & Johnson and Bayer’s Xarelto, once king of the warfarin alternative market, is now chasing chasing Pfizer and Bristol-Myers Squibb’s Eliquis. But with a new approved indication in the books—its eighth—it’s not backing down. The FDA on Monday approved Xarelto to help prevent blood clots for acutely ill patients without a high risk of bleeding during… Read More »
Boston’s South Shore Health System was facing some challenges with five affiliated OB/GYN physician groups across 40 referring physicians: patient confusion, missed revenue, and negatively impacted Hospital Consumer Assessment of Healthcare Providers and Systems scores. To overcome these challenges, South Shore built a smartphone app. Using “app-as-a-service” technology and specialized blueprints, the hospital developed a mobile… Read More »